However, these patients had unique sets of clinical manifestations, different from that of other patients with mutations in SLC29A3. In particular, they displayed no cutaneous hyperpigmentation and the mucocutaneous lesions seemed to be restricted to the nasal mucosa, resulting in the initial diagnosis of RS. The gene discussed is SLC29A3; the disease is X-linked retinoschisis.